5,6,7,8-Tetrahydroquinazoline-2,4(1H,3H)-dione, 95.0%, 1g

1-(5-Bromoindolin-1-yl)ethanone, 95.0%, 1g

2,2,2-Trichloro-1-[1-(2-nitro-4-trifluoromethyl-phenyl)-1H-pyrrol-2-yl]-ethanone, 95.0%, 5g

5-Bromo-2-chloro-N-cyclopropylbenzamide, 95.0%, 250mg

6-Bromo-2H-isoquinolin-1-one, 97.0%, 250mg

2-(4-Ethylbenzoyl)pyridine, 97.0%, 1g

GC capillary column ROTI®Cap-5, 25 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2-Bromo-5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazine, 97%, 100mg

Methyl Nonafluorobutyl Ether, 95.0%, 5g

4-Bromo-2-fluoro-3-iodopyridine, 97%, 100mg

(R)-2-((tert-Butoxycarbonyl)amino)-5-methoxy-5-oxopentanoic acid, 97%, 100g

N'-[1-(4-Bromo-phenyl)-meth-(E)-ylidene]-N,N-dimethyl-ethane-1,2-diamine, 95.0%, 1g

Methyl 3-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 100mg